CSIMarket Company Name, Ticker, Customers, else..
 
Vivani Medical Inc   (NASDAQ: VANI)
 
Price: $1.2699 $-0.05 -3.430%
Day's High: $1.309999942779541 Week Perf: -8.64 %
Day's Low: $ 1.26 30 Day Perf: -8.64 %
Volume (M): 141,636 52 Wk High: $ 1.92
Volume (M$): $ 0 52 Wk Avg: $1.32
Open: $1.31 52 Wk Low: $0.92



 Market Capitalization (Millions $) 111
 Shares Outstanding (Millions) 87
 Employees 42
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -26
 Cash Flow (TTM) (Millions $) 13
 Capital Exp. (TTM) (Millions $) 1

Business Description


Vivani Medical Inc is a healthcare company that specializes in medical devices and equipment. They develop and manufacture advanced medical products to meet the needs of healthcare professionals and patients. The company focuses on innovative technologies and solutions to improve patient care and help healthcare providers deliver better outcomes. Vivani Medical Inc is committed to continually research, develop, and produce high-quality medical products that meet rigorous standards and regulations. Their product portfolio includes a wide range of medical devices, such as diagnostic equipment, monitoring systems, and therapeutic devices. The company aims to contribute to the advancement of healthcare by providing innovative and reliable solutions for various medical needs.


   Company Address: 1350 S. Loop Road Alameda 94502 CA
   Company Phone Number: 506-8462   Stock Exchange / Ticker: NASDAQ VANI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DRIO   -7.26%    
EMBC   -13.27%    
GCTK   -10.48%    
MDT   -0.24%    
MODD   -21.97%    
TNDM   -10.99%    
• View Complete Report
   



Business Update

In a transformative stride forward in the battle against obesity, Vivani Medical, Inc. (Nasdaq VANI), a pio...

Published Thu, Dec 19 2024 1:47 PM UTC

Innovative Leap in Obesity Treatment: Vivani Medical Initiates First-in-Human Trial of GLP-1 Implant in Australia In a transformative stride forward in the battle against obesity, Vivani Medical, Inc. (Nasdaq: VANI), a pioneering name in the biopharmaceutical domain, has commenced its groundbreaking first-in-human clinical trial of an exenatide implant in Australia. This ini...
Business Update

Vivani Medical Propels Forward with $5M Boost and Novel Drug Implant Progress,

Published Wed, Nov 13 2024 2:36 PM UTC

Vivani Medical Advances Innovative Drug Implants Amidst Strong Financial Backing Alameda, Calif. - In a compelling combination of scientific progress and strategic financial maneuvers, Vivani Medical, Inc. (Nasdaq: VANI), a leader in the development of miniaturized, long-acting drug implants, has unveiled its third-quarter financial results for 2024, alongside a noteworthy b...
Business Update

title Vivani Medicals Miniature Obesity Implant A Game-Changing Breakthrough in Chronic Weight Management

Published Thu, Jul 11 2024 1:21 PM UTC

Vivani Medical Sets Sights on Breakthrough Miniature Obesity Implant ProgramALAMEDA, Calif. - Vivani Medical, Inc. (Nasdaq: VANI), a pioneering biopharmaceutical company specializing in long-term drug implants, recently provided an update on its clinical development plans for the NPM-115 program. This innovative initiative aims to tackle the pressing issue of chronic weight ...
Business Update

Vivani Medical Receives FDA Clearance and Lifts Clinical Hold for Revolutionary Miniature Subdermal GLP-1 Drug Implant

Published Thu, Jun 13 2024 12:47 PM UTC

Vivani Medical, a pioneering biopharmaceutical company based in Alameda, California, has announced a significant breakthrough in the field of long-term drug implants. The U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) and lifted the clinical hold on NPM-119, Vivani s groundbreaking miniature long-term subdermal GLP-1 drug i...
Business Update

Vivani Medical Unveils Breakthrough in Feline Healthcare: Innovative OKV-119 Implant Sh...

Published Tue, May 28 2024 2:38 PM UTC

Pioneering the Future of Veterinary Medicine: Vivani Medical Announces Landmark Progress in Combatting Feline Obesity with Innovative OKV-119 Implant In a remarkable stride towards revolutionizing the realm of veterinary medicine, Vivani Medical, Inc. (Nasdaq: VANI), a cutting-edge biopharmaceutical company renowned for developing miniaturized, long-term drug implants, has h...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 2.59
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 5.83
PEG (TTM) 0.12

Financial Strength Current
Quick Ratio 2.99
Working Capital Ratio 3.25
Leverage Ratio (MRQ) 1.2
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0.49 $
Revenues (TTM) -
Cash Flow (TTM) 0.15 $
Cash 0.23 $
Book Value 0.22 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -626,500
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.